ENAGenomicsSCICC Lab, Molecular Oncology, C.R.O. of Aviano - National Cancer Institutehttps://www.ebi.ac.uk/ena/browser/view/PRJNA349480Homo sapiensxref:PubMed:28174235A miRs expression profiling of a total of 746 miRs (664 human + 82 viral) in 72 Head and Neck Squamous Cell Carcinoma (HNSCC) primary tumors to classify patients at high risk to develop recurrences Overall design: In the study presented here, we screened a cohort of 44 HNSCC primary tumors, followed up for two years, for the expression of a total of 746 miRs, to identify a miRs signature that classify patients at high risk to develop recurrencesENAHuman, Modern., human being, Man (Taxonomy), Homo sapiens, man, Man, human, Modern ManOropharyngeal Squamous Cell Carcinoma, Relapse, Carcinoma, Squamous Cell Carcinoma of the Mouth, Squamous Cell Carcinoma of the Nasal Cavity, Risk, Recrudescences, Laryngeal Squamous Cell Carcinoma, Risks, Squamous Cell Carcinoma of the Head and Neck, carcinoma of the head and neck, Head And Neck, Oral Tongue Squamous Cell Carcinoma, Head And Neck Squamous Cell Carcinomas, Oral Squamous Cell Carcinomas, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Larynx, Recurrences., Client, Hypopharyngeal Squamous Cell Carcinoma, Relative, Oral Cavity Squamous Cell Carcinoma, Patient, Recrudescence, Clients, Squamous Cell Carcinoma of Larynx, Relative Risks, Oral Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Relapses, HNSCC, Squamous Cell of Head and Neck, Relative RiskfalseHomo sapiensmiRs expression profile to predict HNSCC patients at high risk to develop recurrence2025-09-242017-10-03PRJNA349480GSE89000960628174235